Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin

Biochemical and Biophysical Research Communications

Volumn 316, Issue 2, 2004, Pages 348-355

  Kim, Sujong ^a   Kang, Byung Young ^a   Cho, Si Yong ^a   Sung, Dae Suk ^a   Chang, Hui Kyung ^a   Yeom, Myung Hun ^a   Kim, Duk Hee ^a   Sim, Young Chul ^a   Lee, Yong Sung ^b  

^a AmorePacific Corporation   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

cDNA microarray; Compound K; Ginsenosides; HaCaT cell; Hyaluronan synthase 2; Skin

Indexed keywords

20 O BETA DEXTRO GLUCOPYRANOSYL 20 PROTOPANAXADIOL; BINDING PROTEIN; COMPLEMENTARY DNA; DRUG METABOLITE; GINSENOSIDE; HYALURONAN BINDING PROTEIN; HYALURONIC ACID; PROTOPANAXADIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DERMIS; DNA MICROARRAY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYALURONAN SYNTHASE 2 GENE; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; UPREGULATION;

ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; EPIDERMIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GINSENOSIDES; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; KERATINOCYTES; MICE; MICE, INBRED HRS; SKIN; UP-REGULATION;

PANAX GINSENG;

EID: 1542407770     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.046     Document Type: Article

References (32)

1. Lee F.C. Facts about Ginseng, the Elixir of Life. 1992;Hollyn International, New Jersey.
2. Huang K.C. The Pharmacology of Chinese Herbs. 1999;CRC Press, Florida.
3. Gillis C.N. Panax ginseng pharmacology: a nitric oxide link? Biochem. Pharmacol. 54:1997;1-8.
4. Kikuchi Y., Sasa H., Kita T., Hirata J., Tode T., Nagata I. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anticancer Drugs. 2:1991;63-67.
5. Tode T., Kikuchi Y., Kita T., Hirata J., Imaizumi E., Nagata I. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J. Cancer Res. Clin. Oncol. 120:1993;24-26.
6. Lee Y.N., Lee H.Y., Chung H.Y., Kim S.I., Lee S.K., Park B.C., Kim K.W. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells. Eur. J. Cancer. 32A:1996;1420-1428.
7. Park J.A., Lee K.Y., Oh Y.J., Kim K.W., Lee S.K. Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett. 121:1997;73-81.
8. Shinkai K., Akedo H., Mukai M., Imamura F., Isoai A., Kobayashi M., Kitagawa I. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn. J. Cancer. Res. 87:1996;357-362.
9. Yu S.C., Li X.Y. Effect of ginsenoside on IL-1β and IL-6 mRNA expression in hippocampal neurons in chronic inflammation model of aged rats. Acta Pharmacol. Sin. 21:2000;915-918.
10. Akao T., Kida H., Kanaoka M., Hattori M., Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50:1998;1155-1160.
11. Hasegawa H., Sung J.H., Hur J.D. Ginseng intestinal bacterial metabolite IH901 as a new antimetastatic agent. Arch. Pharm. Res. 20:1997;539-544.
12. Bae E.A., Choo M.K., Park E.K., Park S.Y., Shin H.Y., Kim D.H. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol. Pharm. Bull. 25:2002;743-747.
13. Choi S. Epidermis proliferative effect of the Panax ginseng ginsenoside Rb2. Arch. Pharm. Res. 25:2002;71-76.
14. Surh Y.J., Na H.K., Lee J.Y., Keum Y.S. Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer. J. Korean Med. Sci. 16(Suppl):2001;S38-S41.
15. Chang L.K., Whitaker D.C. The impact of herbal medicines on dermatologic surgery. Dermatol. Surg. 27:2001;759-763.
16. Pribitkin E.D., Boger G. Herbal therapy: what every facial plastic surgeon must know. Arch. Facial Plast. Surg. 3:2001;127-132.
17. Keum Y.S., Park K.K., Lee J.M., Chun K.S., Park J.H., Lee S.K., Kwon H., Surh Y.J. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett. 150:2000;41-48.
18. Kim S.H., Jeong K.S., Ryu S.Y., Kim T.H. Panax ginseng prevents apoptosis in hair follicles and accelerates recovery of hair medullary cells in irradiated mice. In Vivo. 12:1998;219-222.
19. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:1988;761-771.
20. Lee K.H., Chang M.Y., Ahn J.I., Yu D.H., Jung S.S., Choi J.H., Noh Y.H., Lee Y.S., Ahn M.J. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem. Biophys. Res. Commun. 296:2002;1125-1133.
21. Mian N. Analysis of cell-growth-phase-related variations in hyaluronate synthase activity of isolated plasma-membrane fractions of cultured human skin fibroblasts. Biochem. J. 237:1986;333-342.
22. Laurent T.C., Fraser J.R. Hyaluronan. FASEB J. 6:1992;2397-2404.
23. Juhlin L. Hyaluronan in skin. J. Intern. Med. 242:1997;61-66.
24. Fleischmajer R., Perlish J.S., Bashey R.I. Human dermal glycosaminoglycans and aging. Biochim. Biophys. Acta. 279:1972;265-275.
25. Longas M.O., Russell C.S., He X.Y. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr. Res. 159:1987;127-136.
26. Ghersetich I., Lotti T., Campanile G., Grappone C., Dini G. Hyaluronic acid in cutaneous intrinsic aging. Int. J. Dermatol. 33:1994;119-122.
27. Sobel H., Cohen R.A. Effect of estradiol on hyaluronic acid in the skin of aging mice. Steroids. 16:1970;1-3.
28. Mori Y., Uzuka M., Nishina H., Tarui Y. Regulation of hyaluronate synthesis in the skin. Kligman A.M., Takase Y. Cutaneous Aging. 1988;335-349 University of Tokyo Press, Tokyo.
29. Schmidt J.B., Binder M., Demschik G., Bieglmayer C., Reiner A. Treatment of skin aging with topical estrogens. Int. J. Dermatol. 35:1996;669-674.
30. Dunn L.B., Damesyn M., Moore A.A., Reuben D.B., Greendale G.A. Does estrogen prevent skin aging? Results from the First National Health and Nutrition Examination Survey (NHANES I). Arch. Dermatol. 133:1997;339-342.
31. Pasonen-Seppanen S., Karvinen S., Torronen K., Hyttinen J.M., Jokela T., Lammi M.J., Tammi M.I., Tammi R. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J. Invest. Dermatol. 120:2003;1038-1044.
32. Rilla K., Lammi M.J., Sironen R. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes. J. Cell Sci. 115:2002;3633-3643.